{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:18:27Z","timestamp":1790677107772,"version":"4.1.0"},"reference-count":9,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>The manufacturer of dapoxetine funded randomized clinical trials to study its effect in premature ejaculation (PE). Financial support by pharmaceutical companies, however, may jeopardize the neutrality of clinical research.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>To investigate the scientific process that has been followed in dapoxetine treatment trials and reviews as compared to daily drug treatment trials and reviews with selective serotonin reuptake inhibitors (SSRIs) in men with PE.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A search of Medline and Embase was conducted using the search terms \u201cdapoxetine\u201d or \u201cSSRI.\u201d References of retrieved articles were searched. Only studies describing the use of these drugs in men with PE were included.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>Compared fold-increase intravaginal ejaculation latency time (IELT), geometric mean IELT, and adverse effect profiles between dapoxetine and SSRIs in PE.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Preclinical studies on dapoxetine, including a multicenter study (category A) and reviews (category B), were compared with clinical studies with daily conventional SSRIs in PE (category C). Categories A\/B focused on patient-reported outcomes with less attention for the IELT. The ejaculation-delaying effect of dapoxetine was expressed as natural mean IELT rather than as geometrical mean IELT. Dapoxetine side effects were monthly scored. In contrast, a significant part of category C articles focused on IELT data, used geometric mean IELT outcomes, and one study reported the side effects measured 24\u201348 hours after drug intake using a validated questionnaire. Without the Food and Drug Administration approval, dapoxetine, as well as other SSRIs in PE, is an off-label drug for PE. However, the off-label use of dapoxetine has never been criticized by clinical investigators in contrast to commentaries against the off-label use of daily SSRI treatment in PE.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Manufacturer-funded drug treatment research (categories A and B) is advantageously treated by some authors as compared with nonfunded trials with daily conventional SSRIs (category C). PE drug treatment research is a young and dynamic field, and its development deserves transparency to its development.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/j.1743-6109.2008.00633.x","type":"journal-article","created":{"date-parts":[[2008,3,26]],"date-time":"2008-03-26T10:29:25Z","timestamp":1206527365000},"page":"966-997","source":"Crossref","is-referenced-by-count":34,"title":["Premature Ejaculation and Pharmaceutical Company-Based Medicine: The Dapoxetine Case"],"prefix":"10.1093","volume":"5","author":[{"given":"Marcel D.","family":"Waldinger","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Neurosexology, HagaHospital Leyenburg , The Hague , the Netherlands"},{"name":"Department of Psychopharmacology, Utrecht Institute for Pharmaceutical Sciences and Rudolf Magnus Institute for Neurosciences, Utrecht University , Utrecht , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave H.","family":"Schweitzer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Endocrinology, Reinier de Graaf Groep Hospital , Delft-Voorburg , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,4,1]]},"reference":[{"key":"2024032522281822800_bib1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(06)69373-2","article-title":"Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: An integrated analysis of two double-blind, randomized controlled trials","volume":"368","author":"Pryor","year":"2006","journal-title":"Lancet"},{"key":"2024032522281822800_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1743-6109.2004.04033.x","article-title":"Self-reported premature ejaculation and aspects of sexual functioning and satisfaction","volume":"1","author":"Rowland","year":"2004","journal-title":"J Sex Med"},{"key":"2024032522281822800_bib3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1743-6109.2005.20353.x","article-title":"Premature ejaculation: An observational study of men and their partners","volume":"2","author":"Patrick","year":"2005","journal-title":"J Sex Med"},{"key":"2024032522281822800_bib4","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1743-6109.2007.00528.x","article-title":"The majority of men with lifelong premature ejaculation prefer daily drug treatment: An observational study in a consecutive group of Dutch men","volume":"4","author":"Waldinger","year":"2007","journal-title":"J Sex Med"},{"key":"2024032522281822800_bib5","first-page":"492","article-title":"Multi-national population survey of Intravaginal Ejaculation Latency Time. J Sex","volume":"2","author":"Waldinger","year":"2005","journal-title":"Medicine"},{"key":"2024032522281822800_bib6","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1743-6109.2007.00696.x","article-title":"Geometric mean IELT and premature ejaculation: Appropriate statistics to avoid overestimation of treatment efficacy","volume":"5","author":"Waldinger","year":"2008","journal-title":"J Sex Med"},{"key":"2024032522281822800_bib7","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.eururo.2006.07.004","article-title":"The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: Prevalence, comorbidities, and professional help-seeking","volume":"51","author":"Porst","year":"2007","journal-title":"Eur Urol"},{"key":"2024032522281822800_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/j.1743-6109.2008.00789.x","article-title":"The use of old and recent DSM definitions of premature ejaculation in observational studies: A contribution to the present debate for a new classification of PE in the DSM-V","author":"Waldinger","year":"2008","journal-title":"J Sex Med"},{"key":"2024032522281822800_bib9","first-page":"233","article-title":"Chapter 18: Antidepressants","author":"Chiba","year":"2000","journal-title":"Metabolic drug interactions"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515320130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515320130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/5\/4\/966\/47511791\/jsm_5_4_966.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/5\/4\/966\/47511791\/jsm_5_4_966.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T22:47:53Z","timestamp":1711406873000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/5\/4\/966\/6862319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,1]]},"references-count":9,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2008,4,1]]},"published-print":{"date-parts":[[2008,4,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2008.00633.x","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2008,4]]},"published":{"date-parts":[[2008,4,1]]}}}